Previous Article | Next Article ![]()
Infect. Immun., Jan 1997, 257-260, Vol 65, No. 1
K Takashima, K Tateda, T Matsumoto, Y Iizawa, M Nakao and K Yamaguchi
The production and role of tumor necrosis factor alpha (TNF-alpha) in
pneumococcal pneumonia were investigated in a mouse pneumonia model. When
approximately 10(6) CFU of Streptococcus pneumoniae TUM19 were used to
inoculate CBA/J mice intranasally, TNF-alpha levels in the lungs and serum
began to increase from 1 and 3 days after infection, respectively,
concomitantly with the increase in bacterial counts in the lungs.
Anti-TNF-alpha antibody accelerated bacterial proliferation in the blood
and the death of the mice. Although serum levels of immunoglobulin G
antibody against the infecting bacteria were not affected by the
anti-TNF-alpha antibody treatment, neutrophil counts in the blood were
decreased by the treatment. These results suggest that TNF-alpha produced
in the course of pneumococcal pneumonia prevents bacteremia by increasing
the number of neutrophils in the blood.
Copyright © 1997, American Society for Microbiology
Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice
Department of Microbiology, Toho University School of Medicine, Tokyo, Japan. takasima@lab.takeda.co.jp
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|